Log In
Print this Print this

Aplindore (SLS-006), fumarate

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionSmall molecule partial agonist of the dopamine D2 receptor
Molecular Target Dopamine D2 receptor
Mechanism of ActionDopamine D2 receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat early-stage Parkinson's disease (PD)
Regulatory Designation
PartnerSeelos Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today